Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Orbit ; 34(6): 331-5, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26540241

RESUMEN

INTRODUCTION: To present a series of patients with bisphosphonate induced orbital inflammation, and to review the clinical presentation, radiological features, treatment options and outcomes. METHODS: We present a multicentre, retrospective case series review of patients with a clinico-radiological diagnosis of bisphosphonate induced orbital inflammation and review all the reported cases of this complication in the literature. RESULTS: Four new patients with bisphosphonate induced orbital inflammation were added to the 25 cases in the literature. Intravenous zoledronate was the commonest precipitant (22/29, 75.9%) and inflammation occurred 1-28 (mean 3) days post-infusion. Orbital imaging identified orbital inflammation in 22/29 cases and extra-ocular muscle enlargement in 8/29. Five patients presented with reduced vision of which one - with anterior ischaemic optic neuropathy - did not resolve. The vision resolved in all except one patient, with most requiring steroid treatment. CONCLUSIONS: Bisphosphonates have a pro-inflammatory effect, which can precipitate orbital inflammation. This rare, but potentially serious complication of bisphosphonate treatment should be considered by clinicians using bisphosphonate treatment and by ophthalmologists seeing patients with orbital inflammatory disease.


Asunto(s)
Conservadores de la Densidad Ósea/efectos adversos , Difosfonatos/efectos adversos , Celulitis Orbitaria/inducido químicamente , Miositis Orbitaria/inducido químicamente , Anciano , Anciano de 80 o más Años , Alendronato/efectos adversos , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Femenino , Humanos , Imidazoles/efectos adversos , Masculino , Persona de Mediana Edad , Celulitis Orbitaria/diagnóstico por imagen , Celulitis Orbitaria/fisiopatología , Miositis Orbitaria/diagnóstico por imagen , Miositis Orbitaria/fisiopatología , Pamidronato , Radiografía , Estudios Retrospectivos , Ácido Zoledrónico
2.
Br J Ophthalmol ; 97(6): 735-8, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23603486

RESUMEN

BACKGROUND: We present a series of patients with acute suppurative bacterial dacryoadenitis and review the clinical presentation, microbiology, treatment options and outcome. METHODS: A multicentre, retrospective, case series review of patients with a clinical diagnosis of acute bacterial suppurative dacryoadenitis (ASBD). Records were examined to obtain information regarding patient demographics, presenting symptoms and signs, radiology, microbiology, management, outcomes and follow-up. RESULTS: 11 patients (9 men, 2 women; mean age 43.9 years, range: 6-82 years) were included. Average time to presentation was 2.8 days, and predisposing conditions were found in 45% of cases. Common presenting symptoms were eyelid swelling, pain, redness and diplopia, and common signs were ptosis, discharge and restriction of eye movements. The most common causative bacteria were Staphylococcus aureus and skin flora. Lacrimal gland swelling was universally seen on CT, with globe indentation of displacement in 27% of cases. Intravenous antibiotics were used in 91% of cases, which subsequently resolved over an average period of 9.7 days. Those with abscess formation (n=2) required incision and drainage. CONCLUSIONS: ASBD is a rare condition that resolves quickly if managed appropriately. Underlying anatomical, infectious or inflammatory conditions should be investigated, and skin commensals should be covered with the instigation of antibiotic therapy.


Asunto(s)
Antibacterianos/administración & dosificación , Dacriocistitis/tratamiento farmacológico , Dacriocistitis/microbiología , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Enfermedad Aguda , Administración Oral , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Femenino , Humanos , Aparato Lagrimal/microbiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Supuración/tratamiento farmacológico , Supuración/microbiología , Adulto Joven
3.
Clin Exp Ophthalmol ; 41(6): 567-76, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23279383

RESUMEN

BACKGROUND: Invasive fungal sinusitis is a rare condition that usually occurs in immunocompromised patients and often presents as an orbital apex syndrome. It is frequently misdiagnosed on presentation and is almost always lethal without early treatment. DESIGN: Retrospective case series of 14 consecutive patients with biopsy-proven invasive fungal sinusitis from four tertiary hospitals. PARTICIPANTS: Fourteen patients (10 men and 4 women; age range 46-82 years). METHODS: Retrospective chart review of all patients presenting with invasive fungal sinusitis between 1994 and 2010 at each hospital, with a close analysis of the tempo of the disease to identify any potential window of opportunity for treatment. MAIN OUTCOME MEASURES: Demographic data, background medical history (including predisposing factors), symptoms, signs, radiological findings, histopathological findings, treatment approach and subsequent clinical course were recorded and analysed. RESULTS: Only one patient was correctly diagnosed at presentation. Only two patients were not diabetic or immunocompromised. The tempo was acute in two patients, subacute in nine patients and chronic in three patients. In the subacute and chronic cases, there was about 1 week of opportunity for treatment, from the time there was a complete orbital apex syndrome, and still a chance for saving the patient, to the time there was central nervous system invasion, which was invariably fatal. Only two patients survived - both had orbital exenteration, as well as antifungal drug treatment. CONCLUSIONS: Invasive fungal sinusitis can, rarely, occur in healthy individuals and should be suspected as a possible cause of a progressive orbital apex syndrome.


Asunto(s)
Infecciones Fúngicas del Ojo/microbiología , Micosis/microbiología , Sinusitis/microbiología , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Causas de Muerte , Infecciones Fúngicas del Ojo/diagnóstico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Femenino , Hongos/aislamiento & purificación , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Micosis/diagnóstico , Micosis/tratamiento farmacológico , Pirimidinas/uso terapéutico , Estudios Retrospectivos , Factores de Riesgo , Sinusitis/diagnóstico , Sinusitis/tratamiento farmacológico , Tomografía Computarizada por Rayos X , Triazoles/uso terapéutico , Voriconazol
4.
Med J Aust ; 195(2): 87-8, 2011 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-21770880

RESUMEN

A 62-year-old woman with an autoimmune disease presented with panuveitis and was treated with immune suppression. She subsequently developed herpetic acute retinal necrosis and later died of herpes simplex encephalitis. Acute retinal necrosis usually occurs months to years after herpes simplex encephalitis. In our case, the ocular findings were present for 5 weeks before the encephalitis presented. To our knowledge, this is the first Australian case of acute retinal necrosis preceding herpes simplex encephalitis.


Asunto(s)
Encefalitis por Herpes Simple/inducido químicamente , Glucocorticoides/efectos adversos , Panuveítis/tratamiento farmacológico , Prednisolona/efectos adversos , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Encefalitis por Herpes Simple/tratamiento farmacológico , Femenino , Glucocorticoides/uso terapéutico , Herpes Simple/tratamiento farmacológico , Herpesvirus Humano 1/efectos de los fármacos , Humanos , Persona de Mediana Edad , Prednisolona/uso terapéutico , Síndrome de Necrosis Retiniana Aguda/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...